Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Sep 6;293(6547):591–593. doi: 10.1136/bmj.293.6547.591

Sulphinpyrazone and the platelet serotoninergic mechanism in ischaemic heart disease.

V K Puri, A Rawat, A Sharma, A Mehrotra, M Hasan, K Shanker, M Verma, J N Sinha, K P Bhargava
PMCID: PMC1341380  PMID: 3092937

Abstract

A double blind study in 25 patients with ischaemic heart disease and 20 matched healthy controls examined the effect of sulphinpyrazone on the uptake of serotonin by platelets and the basal concentrations of serotonin in platelets. Uptake was measured using tritium labelled serotonin and basal concentrations estimated spectrophotofluorometrically. Serotonin uptake was significantly increased both in the patients with chronic stable angina of effort and in those with a history of myocardial infarction six months or more previously. Sulphinpyrazone reduced serotonin uptake from 94.25 (SE 8.65) to 57.86 (5.37) cpm/10(8) platelets after 24 weeks of treatment in the group with stable angina and from 137.45 (16.26) to 68.08 (8.38) cpm/10(8) platelets in the myocardial infarction group. Raised basal concentrations in the two groups were also reduced by sulphinpyrazone. Placebo had no effect on serotonin uptake or basal concentrations in either group of patients. The ability of sulphinpyrazone to inhibit uptake and reduce basal concentrations of serotonin in patients with ischaemic heart disease may be yet another mechanism through which this drug exerts its beneficial antiplatelet effect.

Full text

PDF
591

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali M., McDonald J. W. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin. J Lab Clin Med. 1977 Apr;89(4):868–875. [PubMed] [Google Scholar]
  2. BORN G. V., GILLSON R. E. Studies on the uptake of 5-hydroxytryptamine by blood platelets. J Physiol. 1959 Jun 11;146(3):472–491. doi: 10.1113/jphysiol.1959.sp006206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chandler A. B. Mechanisms and frequency of thrombosis in the coronary circulation. Thromb Res. 1974 Jun;4(0):suppl 1–223. doi: 10.1016/0049-3848(74)90144-3. [DOI] [PubMed] [Google Scholar]
  4. Haerem J. W. Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis. 1972 Mar-Apr;15(2):199–213. doi: 10.1016/0021-9150(72)90070-6. [DOI] [PubMed] [Google Scholar]
  5. Latour J. G., Theroux P., Bourassa M. G. Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction. Am J Cardiol. 1982 Nov;50(5):938–944. doi: 10.1016/0002-9149(82)90399-x. [DOI] [PubMed] [Google Scholar]
  6. Maseri A., L'Abbate A., Baroldi G., Chierchia S., Marzilli M., Ballestra A. M., Severi S., Parodi O., Biagini A., Distante A. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med. 1978 Dec 7;299(23):1271–1277. doi: 10.1056/NEJM197812072992303. [DOI] [PubMed] [Google Scholar]
  7. Mehta J., Mehta P., Pepine C. J. Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. 3. Role of tachycardia stress and propranolol. Circulation. 1978 Nov;58(5):881–886. doi: 10.1161/01.cir.58.5.881. [DOI] [PubMed] [Google Scholar]
  8. Oliva P. B., Breckinridge J. C. Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation. 1977 Sep;56(3):366–374. doi: 10.1161/01.cir.56.3.366. [DOI] [PubMed] [Google Scholar]
  9. PRINZMETAL M., KENNAMER R., MERLISS R., WADA T., BOR N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med. 1959 Sep;27:375–388. doi: 10.1016/0002-9343(59)90003-8. [DOI] [PubMed] [Google Scholar]
  10. Sneddon J. M. Blood platelets as a model for monoamine-containing neurones. Prog Neurobiol. 1973;1(2):151–198. doi: 10.1016/0301-0082(73)90019-1. [DOI] [PubMed] [Google Scholar]
  11. Steele P., Battock D., Genton E. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease. Circulation. 1975 Sep;52(3):473–476. doi: 10.1161/01.cir.52.3.473. [DOI] [PubMed] [Google Scholar]
  12. Yamazaki H., Takahashi T., Sano T. Hyperaggregability of platelets in thromboembolic disorders. Thromb Diath Haemorrh. 1975 Sep 30;34(1):94–105. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES